Governor Katie Hobbs releases official proclamation supporting the recognition of “Cancer Caregivers Awareness Week” across Arizona.Continue reading
Category Archives: AZBio News
CancerX Launches New Startup Accelerator to Advance Digital Innovations in Oncology
TAMPA, Fla. – CancerX, co-hosted by Moffitt Cancer Center and the Digital Medicine Society (DiMe) alongside the Office of the National Coordinator for Health Information Technology and the Office of the Assistant Secretary for Health announced the launch of the CancerX Startup Accelerator today at the Future of Cancer Care Summit in Tampa, Fla. It is the first-ever national cancer innovation accelerator initiative with public support from the White House.
ASU startup DNA Biotronix wins grand prize in Skysong Innovations Startup Challenge
November 9, 2023 – An Arizona State University startup is one step closer to developing tiny, noninvasive wearable devices to measure real-time glucose levels in sweat after winning Skysong Innovations’ 2023 Startup Challenge. Four finalists received seed funding.Continue reading
C-Path’s Pioneering Neuroscience Workshop Transforms the Landscape of Neurological Disorder Therapies
TUCSON, Ariz., Nov. 9, 2023 – Critical Path Institute (C-Path) is pleased to announce the release of a new peer-reviewed publication, titled “Transforming Drug Development for Neurological Disorders: Proceedings from a Multi-disease Area Workshop,” now published in Neurotherapeutics, The Journal of the American Society for Experimental Neurotherapeutics.Continue reading
Department of Defense grant supports study of potential treatment for traumatic brain injuries
College of Medicine – Tucson researchers will lead a clinical trial examining one hormone’s ability to reduce impairments following traumatic brain injury.Continue reading
City of Hope appoints Alan H. Bryce, M.D., as chief clinical officer at City of Hope Cancer Center Phoenix and professor of molecular medicine at TGen
PHOENIX, NOVEMBER 7, 2023 — City of Hope®, one of the largest cancer research and treatment organizations in the United States, today announced the appointment of Alan H. Bryce, M.D., as the chief clinical officer at City of Hope Cancer Center Phoenix and professor of molecular medicine at Translational Genomics Research Institute (TGen), part of City of Hope. He joins City of Hope from Mayo Clinic, where he served as chair of the Division of Hematology and Medical Oncology in the Department of Internal Medicine at Mayo Clinic in Arizona and director of Mayo Clinic Comprehensive Cancer Center in Arizona. Continue reading
C-Path’s T1D Consortium New-onset Article Published in The Lancet Diabetes and Endocrinology
Research confirms immune-based therapies improve outcomes in new-onset T1DContinue reading
SenesTech Launches Evolve™ Soft Bait for Rodent Fertility Control
The first and only soft bait product featuring breakthrough, next generation technology that targets rodent populations by using nonlethal methods to restrict fertility.
Ivy Center Announces First Patient Treated in Targeted Phase 0/1 Clinical Trial for High-Grade Glioma
Study tests targeted agent, BDTX-1535, an EGFR inhibitor with brain-penetrant properties Continue reading
ASU researchers working to develop biomarkers to screen for HPV-related cancer
Oropharyngeal cancer — a type of cancer that is difficult to diagnose, treat — is on the rise
Recent studies have highlighted a concerning trend: a rise in oropharyngeal cancer — difficult to diagnose and difficult to treat — linked to the human papillomavirus (HPV). Researchers are keen to spread awareness about this connection, emphasizing the importance of HPV vaccinations for both men and women and expanded testing for those at risk.Continue reading